Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-11-27 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an order passed by a tax authority regarding reversal of Input Tax Credit, interest, and penalty amounts. The document is a regulatory announcement about a legal/tax matter affecting the company, with no financial statements or detailed financial analysis included. It is not a full report, earnings release, or management discussion. The content fits best under Regulatory Filings (RNS) as it is a compliance disclosure about a regulatory order and its impact, without constituting a standalone audit report or financial report.
2024-11-27 English
Issue of Duplicate Share Certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and provides details of the shareholder and share certificate numbers. There is no financial data, no report or presentation, no voting results, no management or board changes, no earnings or audit information. The document is an official regulatory announcement related to share certificates, which does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is a regulatory compliance notification about share certificate issuance, best classified under Regulatory Filings (RNS) as it does not fit other specific categories and is a formal regulatory communication.
2024-11-25 English
The Company has approved issue of duplicate share certificates request in lieu of the original share certificates reported lost/misplaced.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references SEBI regulations and a SEBI circular, indicating compliance with regulatory requirements. The content is about share certificate issuance and does not contain financial statements, management discussion, or any report data. It is an announcement of a corporate action related to share certificates, not a financial report or earnings release. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-25 English
General Updates
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges notifying them about the resignation and last working day of a Key Managerial Person (Ms. Radhika Shah) at Sanofi India Limited. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events including changes in key managerial personnel. The content is an announcement of a management change rather than a financial report, audit, or other types of filings. The document length is short (1540 characters), and it is clearly an announcement of a change in senior management. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-11-13 English
Update on change in Key Managerial Person
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to stock exchanges notifying them about the resignation and last working day of a Key Managerial Person (Ms. Radhika Shah) at Sanofi India Limited. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events including changes in key managerial personnel. The content is an announcement of a management change rather than a financial report, audit, or other types of filings. The document length is short (1540 characters), and it is clearly an announcement of a change in senior management. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-11-13 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss and related disclosures. The content is an intimation or notification about a specific event (loss of share certificates) rather than a financial report, management discussion, or any other detailed corporate filing. It does not contain financial data, audit information, or meeting materials. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.